Insider · CIK 0001517026
Mark Verratti
Files at MYGN (MYRIAD GENETICS INC). First filing -, latest -.
In brief
Mark Verratti files SEC Form 4 as COO at MYGN (MYRIAD GENETICS INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Mark Verratti has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 14, 2026 | MYGN MYRIAD GENETICS INC | FTax withholding Common Stock | -1,069 | $4.91 | $5,249 | 629,646 | Apr 15, 2026 |
| Mar 22, 2026 | MYGN MYRIAD GENETICS INC | FTax withholding Common Stock | -2,055 | $4.58 | $9,412 | 630,715 | Mar 23, 2026 |
| Mar 12, 2026 | MYGN MYRIAD GENETICS INC | AGrant or award Common Stock | +247,423 | $0.00 | $0 | 662,059 | Mar 16, 2026 |
| Mar 13, 2026 | MYGN MYRIAD GENETICS INC | FTax withholding Common Stock | -9,164 | $4.66 | $43k | 652,895 | Mar 16, 2026 |
| Mar 14, 2026 | MYGN MYRIAD GENETICS INC | FTax withholding Common Stock | -5,418 | $4.66 | $25k | 647,477 | Mar 16, 2026 |
| Mar 15, 2026 | MYGN MYRIAD GENETICS INC | FTax withholding Common Stock | -5,611 | $4.66 | $26k | 641,866 | Mar 16, 2026 |
| Mar 15, 2026 | MYGN MYRIAD GENETICS INC | FTax withholding Common Stock | -9,096 | $4.66 | $42k | 632,770 | Mar 16, 2026 |
| Feb 2, 2026 | MYGN MYRIAD GENETICS INC | AGrant or award Common Stock | +32,810 | $0.00 | $0 | 414,636 | Feb 3, 2026 |
| Sep 21, 2025 | MYGN MYRIAD GENETICS INC | FTax withholding Common Stock | -1,085 | $7.77 | $8,430 | 381,826 | Sep 22, 2025 |
| Apr 30, 2025 | MYGN MYRIAD GENETICS INC | AGrant or award Performance-Based Restricted Stock Unitsderivative | +105,785 | $0.00 | $0 | 105,785 | May 1, 2025 |
| Apr 14, 2025 | MYGN MYRIAD GENETICS INC | FTax withholding Common Stock | -1,085 | $8.08 | $8,767 | 382,911 | Apr 15, 2025 |
Questions about Mark Verratti
Answered from the filings on this page, as of the latest one.
Is Mark Verratti buying or selling?
Mark Verratti has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Mark Verratti's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mark Verratti has 0.
Where does Mark Verratti file Form 4?
Mark Verratti has filed Form 4 at MYGN (MYRIAD GENETICS INC) as Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.